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A Systematic Review
Jong Min Lee, MPH,1 Susan Holley, MD,2 Catherine Appleton, MD,2 and Adetunji T. Toriola, MD, MPH, PhD1
Abstract
Introduction: Both bone mineral density (BMD) and breast density are related to reproductive hormone levels.
This suggests that BMD and breast density could be meaningfully associated, and serve as surrogate markers for
breast cancer risk. However, few studies have investigated the association of BMD with percent mammographic
density, making it difficult to draw meaningful conclusions.
Materials and Methods: We conducted a systematic review of studies published in electronic databases till
April 2016 using the following search terms: ‘‘bone density,’’ ‘‘bone mineral density,’’ ‘‘mammographic breast
density,’’ ‘‘breast density,’’ and ‘‘mammographic density.’’ We identified 203 articles, of which 8 met the
inclusion criteria for this review.
Results: BMD does not appear to be associated with percent mammographic density. BMD at the spine was
weakly positively associated with percent mammographic density among postmenopausal women who were not
hormone users, while BMD at the hip and legs was positively associated with percent mammographic density
among premenopausal women. On the other hand, one study reported an inverse association of BMD at the
spine and hip with percent mammographic density among perimenopausal women.
Conclusion: In this review,we foundnoevidenceof anassociationbetweenBMDandpercentmammographicdensity.
Keywords: bone mineral density (BMD), mammographic density, menopause
Introduction
Mammographic density is a strong risk factor for breastcancer. An increased breast density is associated with a
four- to sixfold increased risk of breast cancer.1–4 Likewise,
some studies have suggested that increased bone mineral
density (BMD) might be associated with an increased risk of
breast cancer, especially among postmenopausal women.5,6
Although the underlying mechanisms are still poorly under-
stood, hormonal exposure is thought to play an important role
in driving the association of mammographic density with
breast cancer risk.7–10 In theWomen’s Health Initiative (WHI)
trial, 1 year of estrogen plus progestin use was associated with
a 6% increase in mammographic density.11 Hormonal expo-
sure also plays an important role in BMD.12,13 Longer duration
of exposure to estrogen is positively associatedwith BMD.14–16
Estrogen deficiency during menopause induces cortical
bone loss by inhibiting bone resorption activity, resulting in
decreased bone mass.17–19 Hence, it is possible that similar
etiological pathways involving reproductive hormone expo-
sure may drive the association of mammographic density and
BMD with breast cancer risk. On the other hand, adiposity,
which is a risk factor for postmenopausal breast cancer (but
inversely associated with premenopausal breast cancer), has
divergent effects on mammographic density and BMD.20,21
While body mass index (BMI) is positively associated with
BMD,22,23 it is inversely associated with mammographic
density.24,25 Therefore, the association of BMD with percent
mammographic density may be more complex.
Understanding the association of BMD with percent
mammographic density might provide better knowledge of
how breast cancer intermediaries increase breast cancer risk.
Furthermore, if mammographic density is associated with
BMD, knowing a woman’s breast density might have some
utility in predicting BMD, and possibly future fracture risk
since BMD is a strong predictor of future fracture risk.26 The
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few studies that have investigated the association of BMD
with percent mammographic density,27–34 have produced
conflicting results, and no review of the topic has been un-
dertaken. To extend knowledge on the association of BMD
with percent mammographic density, we conducted a sys-
tematic review of published studies.
Materials and Methods
We identified studies published between January 2000 and
April 2016 using the following databases: PubMed, OVidSP,
BioMed Central, EMBASE, Web of Science, and Scopus.
Search terms included the following: ‘‘bone density,’’ ‘‘bone
mineral density,’’ ‘‘mammographic breast density,’’ ‘‘breast
density,’’ and ‘‘mammographic density.’’ Search queries in the
databases yielded 211 articles (Figure 1). Abstracts and results
were examined if the articles were relevant to our topic of
study. Reference lists of relevant articles were also examined.
From 211 articles, we included studies if they met the fol-
lowing criteria: reported on (1) the association of BMD with
percent mammographic density. Hence, studies using Breast
Imaging-Reporting andData System (BI-RADS) classification
were not included. The exposure was defined as BMD, while
the outcome was defined as percent mammographic density.
(2) Publications were in English language. Eight studies met
the inclusion criteria. From these eight articles, we extracted
information on study design, age, menopausal status, and
number of participants, BMD sites, and confounders. Studies
were available on the following BMD sites in relation to
mammographic density: spine (N= 7), hip (N= 6), and other
sites, including arms, ribs, and overall body (N= 3). We ex-
tracted data on beta coefficient values, 95% confidence inter-
vals (CIs), and p-values from the original studies.
Results
BMD at the spine
Seven studies have investigated the association of BMD at
the spine with percent mammographic density27–33 (Table 1).
No associations were reported in studies that did not stratify
by menopausal status. BMD of the spine was associated with
percent mammographic density in two studies of the five
studies that stratified by menopausal status. Crandall et al.
reported a very weak positive association between BMD at
the spine (b = 0.099, p = 0.08) and percent mammographic
density among postmenopausal women who were not recent
hormone users after adjusting for age, BMI, and cigarette
smoking.29 In another study, the same authors observed an
inverse association between BMD at the spine (b= -20.6
[95% CI: -37.2 to -3.9], p < 0.05) and mammographic den-
sity among early perimenopausal women.30
BMD at the hip
Six studies have investigated the association of BMD at the
hip with percent mammographic density27,29–33 (Table 2). The
studies that investigated associations among all women re-
gardless of menopausal status reported no association.27,31,33
Five studies stratified their analyses by menopausal status.
BMD at the hip was positively associated withmammographic
density in two studies: one among premenopausal women
(b= 0.59, p< 0.05)33 and one among postmenopausal women
who were not recent hormone users (b= 0.156, p< 0.05).29
Conversely, an inverse association was observed among early
perimenopausal women (b= -18.8 [95% CI: -37.0 to -0.6],
p< 0.05).30
BMD at other sites (legs, ribs, arms, and whole body)
Only three studies have investigated the association of
BMD at other sites, including ribs, arms, leg, and whole body,
with mammographic density28,33,34 and two studies reported
no associations overall. However, Sung et al. observed a
positive association of BMD at the legs with mammographic
density among premenopausal women (b = 0.59, p < 0.05)33
(Table 3). A recent study observed a positive association of
BMD at the forearm with percent mammographic density
FIG. 1. Flow diagram of
the literature search.
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Table 1. Summary Description of Studies on the Association of Bone Mineral
Density at the Spine with Percent Mammographic Breast Density
Reference,
country Design
Age
(years) Study participants
Results
(b coefficient
or correlation)
95%
Confidence
interval/p Confounders
Sung et al.,33
Korea
Cross-sectional ‡30 Overall (N = 730) b= 0.27a -0.01 to 0.55 Age, smoking status,
alcohol
consumption,
physical exercise,
number of live
children, age at
menarche, age at
birth of first child,
duration of breast
feeding, use of oral
contraceptives,
hormone
replacement therapy
Premenopausal
(N = 462)
b= 0.21a -0.0 to 0.46
Postmenopausal
(N = 268)
b= 0.42a -0.27 to 1.11
Gupta et al.,32
Kuwait
Cross-sectional 25–74 Premenopausal
(N = 147)
r= 0.158b 0.125 Ethnicity
Postmenopausal
(N = 96)
r= 0.021b 0.798
Crandall et al.,30
United States
Cross-sectional 42–52 Early
Perimenopausal
(N = 249)
b =-20.6c 0.02 Age, BMI, ethnicity,
study site, number
of pregnancies,
alcohol
consumption, age at
first childbirth,
smoking status,
physical activity
score
Premenopausal
(N = 56)
b =-29.0c 0.23
Dite et al.,27
Australia
Cross-sectional N/A Overall (N = 268) b= -0.02d 0.79 Age, BMI, smoking
statusPremenopausal
(N =N/A)
b= -0.10d 0.33
Postmenopausal/past
or never HT
(N =N/A)
b= 0.02d 0.85
Postmenopausal/
current or recent
HT users
(N =N/A)
b= 0.24d 0.19
Dite et al.,28
Australia
Longitudinal 38–71 Overall (N = 134) r= 0.015e 0.8 Age at mammogram,
age at bone scan,
height and weight
Crandall et al.,29
United States
Cross-sectional 45–64 Postmenopausal
women who are
not recent HT
users (N= 417)
b= 0.099d 0.08 Age, BMI, smoking
status
Postmenopausal
women who are
recent HT users
(N = 173)
b= -0.065d 0.44
Kerlikowske
et al.,31
United States
Cross-sectional
and nested
case-control
study
‡28 Overall (N = 405) r= 0.01f 0.87 Age, BMI, ethnicity,
age at first live
birth, HT use
Premenopausal
(N = 20)
r= 0.09f 0.71
Postmenopausal/past
or never HT
(N = 142)
r= 0.06f 0.48
Postmenopausal/
current or recent
HT (N = 153)
r= 0.00f 1.00
aBeta coefficients assessed by a linear mixed model.
bSpearman’s correlation coefficient.
cBeta coefficients assessed by a linear regression model. Current/recent hormone users were excluded in this model.
dBeta coefficients assessed by a linear regression model.
eCross-trait cross-twin correlations.
fPearson’s correlation coefficient.
BMI, body mass index; HT, hormone therapy; N/A, not available.
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Table 2. Summary Description of Studies on the Association of Bone Mineral Density
at the Hip with Percent Mammographic Breast Density
Reference, country Design
Age
(years) Study participants
Results
(b coefficient or
correlation)
95%
Confidence
interval/p Confounders
Sung et al.,33
Korea
Cross-sectional ‡30 Overall (N = 730) b = 0.75a 0.30 to 1.21 Age, smoking status,
alcohol
consumption,
physical exercise,
number of live
children, age at
menarche, age at
birth of first child,
duration of breast
feeding, use of oral
contraceptives,
hormone
replacement
therapy
Premenopausal
(N= 462)
b = 0.59a 0.16 to 1.02
Postmenopausal
(N= 268)
b = 0.45a -0.46 to 1.36
Gupta et al.,32
Kuwait
Cross-sectional 25–74 Premenopausal
(N= 147)
r = 0.094b 0.385 Ethnicity
Postmenopausal
(N= 96)
r = 0.082b 0.342
Crandall et al.,30
United States
Cross-sectional 42–52 Early
Perimenopausal
(N= 301)
b= -18.8c 0.04 Age, BMI, ethnicity,
study site, number
of pregnancies,
alcohol
consumption, age
at first childbirth,
smoking status,
physical activity
score
Premenopausal
(N= 80)
b = 3.9c 0.87
Dite et al.,27
Australia
Cross-sectional N/A Overall (N = 268) b = -0.09d 0.41 Age, BMI, and
smoking statusPremenopausal
(N=N/A)
b = -0.23d 0.06
Postmenopausal/
past or never HT
(N=N/A)
b = 0.05d 0.78
Postmenopausal/
current or recent
HT users
(N=N/A)
b = -0.07d 0.79
Crandall et al.,29
United States
Cross-sectional 45–64 Postmenopausal
women who are
not recent HT
users (N= 417)
b = 0.156d 0.04 Age, BMI, smoking
status
Postmenopausal
women who are
recent HT users
(N= 173)
b = -0.073d 0.51
Kerlikowske
et al.,31
United States
Cross-sectional
and nested
case–control
study
‡28 Overall (N = 424) r = -0.06e 0.22 Age, BMI, ethnicity,
age at first live
birth, HT use
Premenopausal
(N= 22)
r = -0.00e 1.00
Postmenopausal/
past or never HT
(N= 149)
r = -0.11e 0.17
Postmenopausal/
current or recent
HT (N = 158)
r = -0.06e 0.47
aBeta coefficients assessed by a linear mixed model.
bSpearman’s correlation coefficient.
cBeta coefficients assessed by a linear regression model. Current/recent hormone users were included in this model.
dBeta coefficients assessed by a linear regression model.
ePearson’s correlation coefficient.
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among postmenopausal women, but not among premeno-
pausal women (Table 3).
Discussion
In this review, we identified eight studies published up till
April 2016 that evaluated the association of BMD with
percent mammographic density. There is little evidence to
support an association between BMD and percent mam-
mographic density. However, there appears to be a weak
association between BMD at the spine and hip and percent
mammographic density, which may be modified by meno-
pausal status. While BMD at the spine was weakly posi-
tively associated with percent mammographic density
among postmenopausal women who were not hormone
users, BMD at the spine and hip was weakly negatively
associated with mammographic density among perimeno-
pausal women. On the other hand, BMD at the hip and legs
was weakly positively associated with percent mammo-
graphic density among premenopausal women. Since re-
productive hormone changes across a menstrual cycle as
well as across the menopausal transition,35 it is possible that
menopausal status, which affects reproductive hormone
levels, modifies the effect of BMD on percent mammo-
graphic density.
Hormonal status, BMD, and mammographic density
A few of the studies observed a small, but statistically sig-
nificant association of BMD on percent mammographic den-
sity after stratifying by menopausal status. This suggests that
changes in reproductive hormone levels, particularly estrogen,
over the course of the reproductive life cycle might moderate
the association of BMD and percent mammographic density.
Table 3. Summary Description of Studies on the Association of Bone Mineral Density
at Other Sites (Ribs, Arms, Body) with Percent Mammographic Breast Density
Reference,
country Design
Age
(years)
Study
participants
Results
(b coefficient
or correlation)
95%
Confidence
interval/p Confounders
Moseson
et al.,34
Mexico
Prospective
cohort
study
N/A Premenopausal
(N = 955)
Forearm (BMD:
0.41–0.45): 0.2a
-2.30 to 2.71 Family history of breast
cancer, age at
menarche, smoking,
alcohol, hormone use,
daily calcium intake,
BMI, number of
pregnancies, age at
first pregnancy,
contraceptive use
Forearm (BMD:
0.45–0.48): -0.91a
-3.42 to 1.61
Forearm (BMD:
0.48+): -0.21a
-2.82 to 2.40
Postmenopausal
(N = 552)
Forearm (BMD:
0.35–0.40): 0.77a
-2.32 to 3.86
Forearm (BMD:
0.40–0.44): 5.06a
1.87 to 8.26
Forearm (BMD:
0.44+): 4.44a
1.11 to 7.77
Sung et al.,33
Korea
Cross-
sectional
‡30 Overall (N= 730) Legs: b = 0.661 0.16 to 1.15 Age, smoking status,
alcohol consumption,
physical exercise,
number of live
children, age at
menarche, age at
birth of first child,
duration of breast
feeding, use of oral
contraceptives,
hormone replacement
therapy
Premenopausal
(N = 462)
Legs: b = 0.59a 0.05 to 1.14
Postmenopausal
(N = 268)
Legs: b = 0.39a -0.51 to 1.28
Overall (N= 730) Arms: b = 0.93a 0.28 to 1.57
Premenopausal
(N = 462)
Arms: b = 0.43a -0.05 to 0.92
Postmenopausal
(N = 268)
Arms: b = 1.87a -0.09 to 3.82
Overall (N= 730) Ribs: b = 1.11a 0.29 to 1.92
Premenopausal
(N = 462)
Ribs: b = 0.59a -0.07 to 1.24
Postmenopausal
(N = 268)
Ribs: b = 0.91a -1.53 to 3.36
Overall (N= 730) Whole body:
b= 0.381
-0.14 to 0.90
Premenopausal
(N = 462)
Whole body:
b= 0.46a
-0.10 to 1.03
Postmenopausal
(N = 268)
Whole body:
b= 0.005a
-0.89 to 0.90
Dite et al.,28
Australia
Longitudinal 38–71 Overall (N= 134) Arms: r = 0.0702 0.3 Age at mammogram,
age at bone scan,
height and weightOverall (N= 134) Neck: r = -0.031b 0.6
aBeta coefficients assessed by a linear mixed model.
bCross-trait cross-twin correlations.
BMD, bone mineral density.
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Estrogen levels in women decrease with aging.36,37 The loss of
ovarian estrogen during menopause is associated with a de-
cline in BMD.17,37 Postmenopausal women who use meno-
pausal estrogen therapy for more than 7 years have higher
BMD than those who had not taken estrogen therapy.38 Fur-
thermore, changes in reproductive hormones affect breast
density as well,7 although this appears mainly due to proges-
terone.11 This increase in percent mammographic density was
greater among postmenopausal women with the use of estro-
gen/progestin combination therapy, but not with the use of
estrogen only.39 Therefore, studies evaluating the associations
of BMD with mammographic density need to consider hor-
monal status, with respect to menopausal status and use of
menopausal hormonal therapy. Of the seven studies in this
review, only four stratified their analyses by both menopausal
status and use of menopausal hormonal therapy.27,29–31
Furthermore, because combined menopausal hormone
therapy (estrogen plus progestin) impacts breast density ra-
ther than estrogen alone, it is important for future studies to
specify what type of menopausal hormone therapy study
participants used.
BMI, BMD, and mammographic density
There is a complex relationship between adiposity, breast
cancer and breast cancer risk factors. Elevated BMI during
the premenopausal years has a protective effect on pre-
menopausal breast cancer, but during the postmenopausal
years, elevated BMI is associated with increased breast
cancer risk.40,41 In addition, increased BMI is positively
associated with BMD, but inversely associated with mam-
mographic density.42–44 For postmenopausal women, as
BMI increases, estrogen levels increase due to the conver-
sion of androgens to estrogen in adipose tissue.45 In addi-
tion, a recently published study reported no association
overall, but a positive association between BMD and per-
cent mammographic density among obese women, and an
inverse association among leaner women.34 This suggests a
complex association. Nevertheless, studies evaluating the
association of BMD with percent mammographic density
have not stratified their analyses by BMI, except for one
conducted among Kuwaiti women.32 It should be noted that
one study not included in this review, because it reported
breast density using the BI-RADS classification rather than
percent mammographic density, reported a small, but sig-
nificant negative association between BMD at hip and breast
density among postmenopausal women with normal weight
and no relationship in overweight or obese women.46
Scattered fibroglandular densities and heterogeneously
dense categories have wide percent mammographic density
ranges and have large overlaps of percentage density in
qualitative BI-RADS categories 2–4, and this may introduce
limitations to their study.47,48
The limitations of this review need to be taken into con-
sideration when interpreting the results. Because of the het-
erogeneity of studies and limited data on each BMD site, we
performed a systematic review, rather than a meta-analysis,
hence no additional statistical analyses were conducted.
In conclusion, there is no evidence to support an associa-
tion between BMD and percent mammographic density. Any
potential association is weak at best, which argues against the
need for further studies.
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